Withus Pharmaceutical. Co., LTD
330350 | KO
Overview
Corporate Details
- ISIN(s):
- KR7330350000
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 서초구 동산로12길 9, 서초구
- Website:
- https://withuspharm.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 942.7 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 918.9 KB | ||
| 2025-03-28 00:00 |
AGM Information
정기주주총회결과
|
Korean | 22.9 KB | ||
| 2025-03-28 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 10.0 KB | ||
| 2025-03-20 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 17.9 KB | ||
| 2025-03-20 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 404.2 KB | ||
| 2025-03-13 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 124.2 KB | ||
| 2025-03-10 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 12.2 KB | ||
| 2025-03-10 00:00 |
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
|
Korean | 4.6 KB | ||
| 2025-02-12 00:00 |
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 10.9 KB | ||
| 2024-12-16 00:00 |
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2024-11-20 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.5 KB | ||
| 2024-11-20 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 74.4 KB | ||
| 2024-11-14 00:00 |
Quarterly Report
분기보고서 (2024.09)
|
Korean | 840.0 KB | ||
| 2024-09-19 00:00 |
Regulatory Filings
생산중단
|
Korean | 8.7 KB |
Automate Your Workflow. Get a real-time feed of all Withus Pharmaceutical. Co., LTD filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Withus Pharmaceutical. Co., LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Withus Pharmaceutical. Co., LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops affordable biosimilars for serious diseases using patented, high-yield production tech.
Sweden
XBRANE
Sweden
XBRANE
Develops serum-free media & automated systems for cell therapy & regenerative medicine.
South Korea
373110
South Korea
373110
Engineering antibody & cytokine therapeutics for cancer and autoimmune diseases via its XmAb platform.
United States of America
XNCR
United States of America
XNCR
Advancing DNase & CAR T immune-oncology platforms to treat hard-to-treat cancers.
United States of America
XBIO
United States of America
XBIO
A neuroscience biopharma developing novel therapeutics for epilepsy and depression.
United States of America
XENE
United States of America
XENE
Develops ready-to-use injectable drugs for chronic, metabolic, and rare diseases.
United States of America
XERS
United States of America
XERS
Developing late-stage, uric acid-lowering therapies for gout and progressive kidney disease.
United States of America
XRTX
United States of America
XRTX
Develops improved cancer drugs (PKIs) using patented tech to circumvent secondary patents.
Sweden
XSPRAY
Sweden
XSPRAY
Acquires and develops late-stage drugs for unmet medical needs, focusing on autoimmune diseases.
Israel
XTLB
Israel
XTLB
